HEALTH SYSTEMS

Enhanced pharmacist care improves LDL in patients with dyslipidemia

Enhanced pharmacist care for patients with dyslipidemia improves low-density lipoprotein cholesterol levels, according to a study published in the March issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. » More

CONTINUING EDUCATION

The latest FDA drug approvals: What you need to know

Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

CLINICAL NEWS

3 studies find aspirin reduces risk of cancer deaths, metastasis

Aspirin can reduce the risk for cancer-related mortality and can reduce or prevent the risk for distant metastasis, according to 3 new studies published online by The Lancet and The Lancet Oncology. » More

Antioxidants may not benefit patients with Alzheimer’s disease

Daily supplementation with antioxidants, vitamins E and C, and alpha acid, did not improve memory function in patients with Alzheimer’s disease, according to a new study. » More

ADHERENCE

Study: Texting enhances HIV therapy compliance

Weekly mobile phone text messaging may help patients with human immunodeficiency virus adhere to antiretroviral therapy that is often associated with difficult side effects, according to a study published online March 14 in the Cochrane Database of Systematic Reviews. » More

FDA NEWS

FDA approves first effervescent osteoporosis treatment in a buffered solution

FDA has approved alendronate sodium (Binosto, EffRx Pharmaceuticals) effervescent tablets, the first effervescent osteoporosis treatment in a buffered solution. » More

FDA approves 'dry' nasal aerosol to treat allergy symptoms

FDA has approved beclomethasone dipropionate (QNASL Nasal Aerosol, Teva Pharmaceutical Industries), a “dry” nasal aerosol corticosteroid that treats year-round and seasonal nasal allergy symptoms in people aged 12 years and older. » More

FDA approves once-monthly treatment for anemic adults on dialysis

FDA has approved peginesatide (Omontys, Affymax) to treat anemia in adult dialysis patients who have chronic kidney disease. » More

TECHNOLOGY

Kirby Lester says its KL1 tablet counter a major hit

The  KL1 compact tablet counter has become Kirby Lester’s most successful product launch in its history, the Lake Forest, Ill., company announced. » More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

Digital Edition